Regulatory Affairs Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Regulatory Affairs Market Growth & Trends

The global regulatory affairs market size is expected to reach USD 22.7 billion by 2028 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rise in drug approvals, label expansions of approved products, along with the presence of Fastrack regulatory pathways are anticipated to facilitate the market growth over the forecast period. Technological advancements in regulatory software and the growing digital transformation in the healthcare industry are also expected to contribute to market growth. In addition, the introduction of Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR) is anticipated to not only change the EU regulatory landscape and increase the stringency of regulations but also increase the number of documents required to be created and maintained by companies.

Furthermore, the changes in the Central Administration for Pharmaceutical Affairs (CAPA) scope in Egypt is anticipated to change the medical device registration process in the country. Such changes in local regulations are anticipated to favor market growth. Furthermore, several regulatory changes related to clinical trials, vaccine development, and product approvals, initiated by the global and local regulatory authorities to expedite patient access to Covid-19 treatments and vaccines, are anticipated to positively affect the market growth. Market players are actively involved in the adoption of advanced technologies, strategic collaborations, and mergers & acquisition, to strengthen their market positions and outperform the competition. For instance, in 2020, ICON acquired MedPass, a medical device CRO, reimbursement, and regulatory consultancy firm. This acquisition is aimed at strengthening the medical device and diagnostic research services portfolio of ICON through the addition of new clinical and regulatory capabilities in Europe.

Request a free sample copy or view report summary: Regulatory Affairs Market Report

Regulatory Affairs Market Report Highlights

• Regulatory writing and publishing was the leading service segment in 2019 and is projected to retain its dominant position throughout the forecast years
• This growth is credited to an increase in the outsourcing of selected regulatory functions by major life sciences companies
• The Biologicssegment is anticipated to witness the fastest CAGR over the forecast period due to the increasing popularity of personalized medicines and biosimilars
• The oncology indication segment dominated the market in 2019 and will expand further at a steady CAGR from 2020 to 2027
• This growth can be attributed to the rising cancer cases and mortality rate along with the presence of several innovative pipeline products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-regulatory-affairs-market

Regulatory Affairs Market Segmentation

Grand View Research has segmented the global regulatory affairs market on the basis of service, service provider, company size, categories, product stage, indication, end-use, and region:

Regulatory Affairs Service Outlook (Revenue, USD Million, 2016 - 2028)

• Regulatory Consulting
• Legal Representation
• Regulatory Writing & Publishing
• Product Registration & Clinical Trial Application
• Other Services

Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Outsourcing

Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2016 - 2028)

• Small
• Medium
• Large

Regulatory Affairs Categories Outlook (Revenue, USD Million, 2016 - 2028)

• Drugs
  • Innovator
    • Preclinical
    • Clinical
    • Post Market
  • Generic
    • Preclinical
    • Clinical
    • Post Market
  • Biologics
    • Biotech
      • Preclinical
      • Clinical
      • Post Market
    • ATMP
      • Preclinical
      • Clinical
      • Post Market
    • Biosimilar
      • Preclinical
      • Clinical
      • Post Market
    • Medical Devices
      • Diagnostic
        • Preclinical
        • Clinical
        • Post Market
      • Therapeutic
        • Preclinical
        • Clinical
        • Post Market

Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2016 - 2028)

• Preclinical
• Clinical
• PMA

Regulatory Affairs Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

Regulatory Affairs End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies

Regulatory Affairs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
  • The Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Regulatory Affairs Market

• Accell Clinical Research, LLC.
• GenPact Ltd.
• Criterium, Inc.
• PRA Health Sciences
• Promedica International
• WuXi AppTec, Inc.
• Medpace
• Charles River Laboratories International, Inc.
• Icon plc
• Covance
• Parexel International Corporation
• Freyr

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemiluminescence Immunoassay Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Chemiluminescence Immunoassay Market Growth & Trends

The global chemiluminescence immunoassay market size is expected to reach USD 13.75 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Request a free sample copy or view report summary: Chemiluminescence Immunoassay Market Report

Chemiluminescence Immunoassay Market Report Highlights

• Based on product, consumables dominated the market in 2020 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• In terms of application, the infectious disease segment held the largest share in 2020 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
• By end use, in 2020, the hospitals segment accounted for the largest share in 2020 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
• In North America, the U.S. held the largest share in 2020 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
• Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemiluminescence-immunoassay-market

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Chemiluminescence Immunoassay Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
  • Automated
  • Semi-automated
• Consumables
• Software & Services

Chemiluminescence Immunoassay Application Outlook (Revenue, USD Million, 2016 - 2028)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

Chemiluminescence Immunoassay End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Chemiluminescence Immunoassay Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Chemiluminescence Immunoassay Market

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Manufacturing Market Trends Regulations And Competitive Landscape Outlook to 2028

 Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 957.59 billion by 2028, registering a CAGR of 11.34% over the forecast years, according to a new report by Grand View Research, Inc. The presence of supportive regulatory legislations, patentability norms, and high funding and investments in the pharmaceutical industry are anticipated to drive market growth. In addition, the broadening of preventive care has created significant opportunities in the market.

The high burden of diseases, economic growth leading to a rise in disposable incomes, improvements in healthcare infrastructure, better healthcare financing, and a rise in the geriatric population have spurred the demand for pharmaceutical manufacturing techniques in biotechnology and pharmaceutical companies. These factors have also prompted many individuals to use medications to improve their quality of life and wellness. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues for pharmaceutical manufacturers to accelerate their drug production.

Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize production costs, overcome medicine shortages, and improve efficiencies. For instance, in March 2021, CONTINUUS Pharmaceuticals announced the construction of the first GMP facility using continuous manufacturing equipment. The company has received a contract from the U.S. government for the production of finished dosage forms and critical APIs. North America accounted for the highest revenue share in 2029 as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers.

Request a free sample copy or view report summary: Pharmaceutical Manufacturing Market Report

Pharmaceutical Manufacturing Market Report Highlights

• Conventional drug manufacturing captured a significant revenue share in 2020 owing to the high penetration of small molecules in terms of usage. An increasing number of regulatory approvals has also positively impacted the segment growth
• Outsource drug development accounted for the largest revenue share in 2020 due to continuous efforts undertaken by the key service providers to expand their production capacities
• The Over-the-Counter (OTC) medicines segment is anticipated to grow at the fastest CAGR from 2021 to 2028 due to the continuous transition from prescription to OTC. This shift from prescription medicines to OTC medicines has potentially benefitted the patients both financially and in terms of better health
• The children & adolescents segment is expected to grow at the fastest CAGR from 2021 to 2028 due to the presence of supportive government initiatives that encourage pediatric studies. The Pediatric Research Equity Act and Best Practices for Children Act are among the few initiatives of the FDA that focus on the development of drugs for children
• The retail sale channel segment held the maximum revenue share as a large percentage of individuals use a retail pharmacy as their one-stop-shop for pharmaceutical products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmaceutical-manufacturing-market

Pharmaceutical Manufacturing Market Segmentation

Grand View Research has segmented the global pharmaceutical manufacturing market on the basis of molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:

Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Billion, 2018 - 2028)

• Biologics & Biosimilars (Large Molecules)
• Conventional Drugs (Small Molecules)

Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Billion, 2018 - 2028)

• In-house
• Outsource

Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Billion, 2018 - 2028)

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other Formulations

Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Billion, 2018 - 2028)

• Oral
• Topical
• Parenteral
• Inhalations
• Other Routes of Administration

Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Billion, 2018 - 2028)

• Cardiovascular Diseases (CVDs)
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Other Diseases

Pharmaceutical Manufacturing Prescription Outlook (Revenue, USD Billion, 2018 - 2028)

• Prescription Medicines
• Over-the-counter (OTC) Medicines

Pharmaceutical Manufacturing Age Group Outlook (Revenue, USD Billion, 2018 - 2028)

• Children & Adolescents
• Adults
• Geriatric

Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Billion, 2018 - 2028)

• Retail
• Non-retail

Pharmaceutical Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Pharmaceutical Manufacturing Market

• Hoffmann-La Roche Ltd.
• Novartis AG
• GlaxoSmithKline plc
• Pfizer, Inc.; Merck & Co., Inc.
• AstraZeneca
• Johnson & Johnson
• Sanofi SA
• Eli Lilly and Company
• AbbVie, Inc.
• Sun Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• Takeda Pharmaceuticals, Inc.
• Cipla Ltd.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Near Infrared Imaging Market Report by Opportunity, Demand, Major Driving Factors and Business Growth Strategies

 Near Infrared Imaging Market Growth & Trends

The global near infrared imaging market size is expected to reach USD 405.0 million by 2028, according to a new report by Grand View Research, Inc. expanding at a 9.3% CAGR during the forecast period. The growing use of near-infrared imaging due to advantages such as minimally invasiveness and high efficiency in diagnosing various conditions is anticipated to drive the near-infrared imaging market significantly during the forecast period.

Growing incidences of chronic disorders, especially among the geriatric population is fueling the near infrared imaging market. Alzheimer’s disease, dementia, arthritis, chronic kidney disease, and diabetes, are some of the commonly prevalent diseases that require near infrared imaging for better diagnosis and further decision making for effective treatment.

Expanding applications of the NIR technique in early diagnosis of various neurological conditions is expected to play a significant role in overall market growth. As per National Research University’s Higher School of Economics, neurological disorders are one of the leading causes of disability and death today. They were reported as the leading cause group of Disability Adjusted Life Years, which comprised 16.8% global deaths.

Frequent introduction of technologically advanced systems is expected to have a significant impact on market growth. NIR is preferred as a process monitoring tool, especially in the pharmaceutical industry. Expanding applications of NIR in commercial operations and research activities in biopharmaceutical companies, as well as academic institutes, are expected to fuel the demand for advanced NIR systems in upcoming years.

Request a free sample copy or view report summary: Near Infrared Imaging Market Report

Near Infrared Imaging Market Report Highlights

• By product, reagents segment dominated the market in 2018 owing to the development of novel reagents to identify various types of cancer
• The reagents segment is expected to grow considerably in the future owing to benefits offered by Indocyanine green (ICG), such as real-time angiographic images during brain tumor or vascular surgery
• Cancer surgeries segment is expected to grow considerably in the near future owing to the high prevalence of the disorder, especially in the emerging economies
• Hospitals & clinics segment dominated the market owing to the increase in the number of admissions of cancer patients in clinics and hospitals
• The players profiled in the near infrared imaging market are Shimadzu Corporation  KARL STORZ SE & Co. KG, Stryker, Leica Microsystems, Olympus, Carl Zeiss Meditec AG, Fluoptics, Quest Medical Imaging B.V., Mizuho Medical Co, Ltd.,  Hamamatsu Photonics K.KVisionsense, PerkinElmer, Inc., LI-COR, Inc., and SurgVision

Access Press Release@ https://www.grandviewresearch.com/press-release/global-near-infrared-imaging-market

Near Infrared Imaging Market Segmentation

Grand View Research has segmented the global near infrared imaging market based on product, application, end-user, and region:

Near Infrared Imaging Product Outlook (Revenue, USD Million, 2016 - 2028)

• Devices
  • Near-infrared Fluorescence Imaging Systems
  • Near-infrared Fluorescence & Bioluminescence Imaging Systems 
• Reagents
  • Indocyanine Green (ICG)
  • Other Reagents

Near Infrared Imaging Application Outlook (Revenue, USD Million, 2016 - 2028)

• Preclinical Imaging
• Cancer Surgeries
• Gastrointestinal Surgeries
• Cardiovascular Surgeries
• Plastic/Reconstructive Surgeries
• Other Applications

Near Infrared Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Research Laboratories

Near Infrared Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Near Infrared Imaging Market

• Quest Medical Imaging B.V.
• Stryker
• KARL STORZ SE & Co. KG
• Olympus
• Hamamatsu Photonics K.K
• Mizuho Medical Co, Ltd.
• Shimadzu Corporation
• Leica Microsystems
• Medtronic (Visionsense)
• PerkinElmer, Inc.
• Carl Zeiss Meditec AGLI-COR, Inc.
• Fluoptics
• SurgVision
• PERKINELMER INC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point-of-Care Glucose Testing Market Trends Analysis And Forecast Till 2028: Grand View Research Inc.

 Point-of-Care Glucose Testing Market Growth & Trends

The global point-of-care glucose testing market size is expected to reach USD 4.1 billion by 2028 growing at a CAGR of 3.9%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. 

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Request a free sample copy or view report summary: Point-of-Care Glucose Testing Market Report

Point-of-Care Glucose Testing Market Report Highlights

• Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period
• Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025
• In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry
• North America is the leading regional market due to the higher penetration of novel diagnostic techniques
• Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes
• A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-point-of-care-glucose-testing-market

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market on the basis of product and region:

Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Accu-Chek Inform II
• StatStrip
• Onetouch Verio Flex
• Freestyle Lite
• Accu Check Aviva Meter
• True Metrix
• Bayer CONTOUR Blood Glucose Monitoring System
• i-STAT

Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Point-of-Care Glucose Testing Market

• Hoffmann-La Roche Ltd.
• Abbott
• Nipro
• PlatInium Equity Advisors, LLC (Lifescan, Inc.)
• Nova Biomedical
• ACON Laboratories
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Endotracheal Tube Market Size Is Expected To Reach USD 3.1 Billion by 2028

 Endotracheal Tube Market Growth & Trends

The global endotracheal tube market size is expected to reach USD 3.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Endotracheal tubes are used to supply oxygen or other gases to the lungs. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and an increasing number of surgical procedures, are expected to propel market growth. In addition, technological development pertaining to endotracheal tubes is further expected to contribute to significant market activities during the forecast period. Recently, Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO₂ and Potassium Titanyl Phosphate (KTP) laser surgeries of the laryngeal or tracheal area.

Certain key factors contributing towards market revenue are the growing need for ventilator-associated with pneumonia and increasing geriatric population that are prone to chronic diseases. As per the World Health Organization (WHO) Report 2019, 4,000,000 people die prematurely due to non-treatment of chronic respiratory diseases. A prominent reason for increasing prevalence of respiratory diseases is air pollution. According to the WHO Report 2019, around 2 billion people globally are exposed to indoor toxic air, 1 billion people are exposed to outdoor pollutant air, and around 1 billion people are exposed to tobacco smoke. The above factors are likely to boost the prevalence of respiratory disorders, which in turn shall boost the demand for endotracheal tubes. With opportunities existing, manufacturers are investing in increasing awareness about the technologically advanced endotracheal tube. For instance, and developments in the field of nanobiotechnology and drug design are spaces that may exhibit higher activities for market growth.

The market witnessed a surge after the outbreak of COVID-19 as breathing difficulty is one of the primary symptoms of the infection, which can lead to collapsed lungs. According to American Association for Bronchology and Interventional Pulmonology, performing tracheostomy was recommended in Covid-19 patients with prolonged mechanical ventilation as it is can reduce the risk of infection, further contributing to market growth. However, a sudden upsurge led to certain mismanagement and chaos initially. By the end of 2020, the industry players had geared themselves up to meet all necessary demands, as well as offer smooth product distribution.

Request a free sample copy or view report summary: Endotracheal Tube Market Report

Endotracheal Tube Market Report Highlights

• By product type, the regular endotracheal tube segment held the largest revenue share of 32.0% in 2020 owing to the increasing prevalence of respiratory diseases
• The orotracheal segment held the largest revenue share and accounted for 64.9% in 2020 owing to its high applicability, increased usage, and ease of use
• Based on the end-use segment, the clinics segment accounted for the largest revenue share in 2020 owing to the shorter waiting time at clinics, convenient access to care, and affordability
• North America accounted for the highest revenue share of 37.9% in 2020 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the region
• Asia Pacific is expected to witness the fastest CAGR of 7.7% over the forecast period. Development in healthcare infrastructure is resulting in an increased number of surgeries being performed, eventually fueling market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-endotracheal-tubes-market

Endotracheal Tube Market Segmentation

Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end-use, and region:

Endotracheal Tube Product Type Outlook (Revenue, USD Million, 2018 - 2028)

• Regular
• Reinforced
• Preformed
• Double lumen

Endotracheal Tube Route Type Outlook (Revenue, USD Million, 2018 - 2028)

• Orotracheal
• Nasotracheal

Endotracheal Tube Application Outlook (Revenue, USD Million, 2018 - 2028)

• Emergency Treatment
• Therapy
• Others

Endotracheal Tube End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Endotracheal Tube Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • New Zealand
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Endotracheal Tube Market

• Teleflex Corporation
• Medtronic
• Medline Industries
• Venner Medical
• Sonoma Pharmaceutical
• Hospiteknik Healthcare
• Armstrong Medical
• Airway Innovations
• Smiths Group
• ConvaTec, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laparoscopic Devices Market Poised to Garner Maximum Revenues During 2021 – 2028: Grand View Research Inc.

 Laparoscopic Devices Market Growth & Trends

The global laparoscopic devices market size is anticipated to reach USD 10.8 billion by 2028, expanding at a CAGR of 6.7%, according to a new report by Grand View Research, Inc. Increasing number of bariatric surgeries being performed and adoption of minimally invasive procedures are anticipated to boost the market growth.

According to the American Society for Metabolic and Bariatric Surgery (ASMBS), bariatric surgery is performed when a patient is suffering from obesity and they are not able to lose weight. Thus, growing cases of obesity are contributing to market growth. Increasing preference by surgeons for laparoscopic surgery owing to the benefits, such as small incisions, less healing time, and short hospital stay, is also driving the market.

Technological advancements are further expected to propel market growth. For instance, Medtronic’s LigaSure device is designed to deliver a specific combination of energy and pressure to create consistent seal within its applications. It provides unique combination of energy and pressure to create vessel fusion. Stryker laparoscopes had a combination of high-quality sapphires and rod lens technology used for superior transformation and excellent recognition to maximize image quality during surgical procedures.

Request a free sample copy or view report summary: Laparoscopic Devices Market Report

Laparoscopic Devices Market Report Highlights

• Energy systems led the market in 2018 due to the favorable reimbursement policies and new product launches, such as Olympus Corporation launched THUNDERBEAT, which is safe and versatile
• Bariatric surgery is projected to be the fastest-growing application segment owing to increasing cases of obesity. Moreover, these surgeries offer painless weight reduction and require shorter hospital stay
• North America was the dominant regional market in 2018 owing to higher adoption of minimally invasive surgeries and increased incidence of gallstones

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laparoscopic-devices-market

Laparoscopic Devices Market Segmentation

Grand View Research has segmented the global laparoscopic devices market on the basis of product, application, end-use, and region:

Laparoscopic Devices Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Trocars
• Energy Systems
• Closure Devices
• Suction / Irrigation Devices
• Insufflation Devices
• Laparoscopes
• Hand Access Instruments
• Robot-assisted System

Laparoscopic Devices Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Bariatric Surgery
• Colorectal Surgery
• General Surgery
• Gynecological Surgery
• Urological Surgery
• Others

Laparoscopic Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinic
• Ambulatory

Laparoscopic Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Qatar

List of Key Players of the Laparoscopic Devices Market

• Medtronic
• Stryker Corporation
• Karl Storz SE & CO. Kg
• Johnson and Johnson
• Olympus Corporation
• CONMED Corporation
• Braun Melsungen AG
• The Cooper Companies Inc.
• Richard Wolf GmbH
• Microline Surgical
• BD
• Welfare Medical Ltd.
• DEAM
• Intuitive Surgical
• Shenzen Mindray Bio Medical Electronics Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Printed Surgical Models Market Expected to Deliver Dynamic Progression By 2028

 3D Printed Surgical Models Market Growth & Trends

The global 3D printed surgical models market size is expected to reach USD 1.1 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.6% from 2021 to 2028. This growth can be attributed to the increasing prevalence of chronic disorders, the rising number of surgical procedures, and the growing need for customized healthcare products. Moreover, the growing use of 3D printing in the healthcare industry is also anticipated to positively impact the market.

The COVID-19 pandemic and the subsequent economic slowdown severely impacted the market. This can be attributed to delays in elective and/or non-emergency surgeries resulting in reduced demand for products and services Furthermore, the shutdown of market players’ vendors and customers coupled with reduced client investments also contributed towards a decline in market players’ revenue. Nonetheless, Materialise medical segment reported a nearly 3.7% increase in its Q1 2021 revenue when compared to the same period in 2020, thereby indicating market recovery from the impact of COVID-19 in the next few years.

According to a report by SME, in 2017, anatomical models accounted for nearly 47% of medical 3D printing in terms of application, making it the second most frequently used application field while surgical instruments and cutting guides accounted for nearly 39% of application scope. Thus, indicating a high demand for 3D printed surgical models in the medical industry.

Request a free sample copy or view report summary: 3D Printed Surgical Models Market Report

3D Printed Surgical Models Market Report Highlights

• The orthopedic surgery segment held a market share of more than 30% in 2020 owing to a high prevalence of orthopedic disorders such as arthritis coupled with a growing geriatric population across the globe
• The Fused Deposition Modeling (FDM) segment accounted for the largest market share of nearly 27.0% in 2020 due to high usage of FDM technology in the industry
• The plasticssegment accounted for the largest revenue share of 2020 and is anticipated to witness a CAGR of 15.7% over the forecast period due to high demand for advanced thermoplastic in the market
• North America dominated the market and accounted for the largest revenue share of over 34.0% in 2020 owing to the presence of favorable reimbursement policies and a high adoption rate for advanced medical technologies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-printed-surgical-models-market

3D Printed Surgical Models Market Segmentation

Grand View Research has segmented the global 3D printed surgical models market on the basis of specialty, technology, material, and region:

3D Printed Surgical Models Specialty Outlook (Revenue, USD Million, 2016 - 2028)

• Cardiac Surgery/Interventional Cardiology
  • Annuloplasty (mitral valve repair)
  • Repair Coronary Aneurysm
  • Replacement of Aortic Valve
  • Stent Insertion
  • Repair Congenital Heart Defects
• Gastroenterology Endoscopy of Esophageal
  • Endoscopy of Esophageal lesion
  • Splenectomy
• Neurosurgery
  • Repair Aneurysm
  • Transsphenoidal Excision of Pituitary Gland
  • Remove Brain Tumor
• Orthopedic Surgery
  • Repair Scoliosis
  • Repair Clavicle Fracture
  • Hip Repair
  • Repair Intervertebral Disc
  • Hip Replacement Revision
  • Repair Leg Fracture
  • Osteotomy
• Reconstructive Surgery
  • Facial Reconstruction
  • Hand Reconstruction
  • Breast Reconstruction
  • Mastoidectomy
  • Cleft Palate Correction
• Surgical oncology
  • Removal of Adrenal Tumor
  • Removal of Liver Tumor
  • Endoscopic Removal of Cardiac Lesion
  • Thoracic Removal of Lung Tumor
  • Removal of Renal Tumor
• Transplant Surgery
  • Cardiac Surgery/ Interventional Cardiology
  • Heart Transplant
  • Liver Transplant
  • Lung Transplant
  • Kidney Transplant

3D Printed Surgical Models Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Stereolithography (SLA)
• ColorJet Printing (CJP)
• MultiJet/PolyJet Printing
• Fused Deposition Modeling (FDM)
• Others

3D Printed Surgical Models Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Polymer
• Plastic
• Others

3D Printed Surgical Models Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Printed Surgical Models Market

• Stratasys Ltd.
• 3D Systems, Inc.
• Lazarus 3D, LLC
• Osteo3D
• Axial3D
• Onkos Surgical
• Formlabs
• Materialise NV
• 3D LifePrints U.K. Ltd.
• WhiteClouds Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Diabetes Devices Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2028

 Diabetes Devices Market Growth & Trends

The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Request a free sample copy or view report summary: Diabetes Devices Market Report

Diabetes Devices Market Report Highlights

• North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches
• By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate
• In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage
• In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements
• In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage
• In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices
• By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies
• By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment
• The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diabetes-devices-market

Diabetes Devices Market Segmentation

Grand View Research has segmented global diabetes devices market on the basis of type, distribution channel, end-use, and region:

Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• BGM Devices
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Homecare
• Diagnostic Centers

Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Czech Republic
  • Poland
  • Switzerland
  • Turkey
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Oman

List of Key Players of Diabetes Devices Market

• Medtronic plc
• Abbott Laboratories
• Hoffmann-La-Ltd.
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Ypsomed Holdings
• Companion Medical
• Sanofi
• Valeritas Holding Inc.
• Novo Nordisk
• Arkray, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.